N.1 is changing the way that benchtop discovery is being taken into the clinic.

N.1 is addressing pressing needs in areas such as N-of-1 medicine, digital health and therapeutics, augmented cognition and training, and robotics, among other areas.

The core objective of our R+D program is clear:

The first-in-human deployment of interventional, Institute-driven technologies.

This objective has led to 10 ongoing/approved clinical studies.

These studies have resulted in life-saving outcomes.